Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult ...
Daily Journal

LSD shows promise for reducing anxiety in drugmaker’s midstage study

WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...
WSLS 10

LSD shows promise for reducing anxiety in drugmaker's midstage study

WASHINGTON – LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in ...
Hosted on MSN

LSD shows promise for reducing anxiety, shows drugmaker's study

LSD reduced symptoms of anxiety in a mid-stage recent study, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the US for more than half ...